Aberdeen Group plc

13D and 13G Filings

Issuer % of Class Filed
Schedule 13G · 14 securities · passive
Equillium, Inc. 13G/A
EQ · 29446K106
7.0% 11/4/2026
Event 9/30/2026
Immunic, Inc. 13G/A
IMUX · 4525EP200
8.0% 11/2/2026
Event 9/30/2026
Codexis, Inc. 13G/A
CDXS · 192005106
9.9% 10/30/2026
Event 9/30/2026
Freenome, Inc. 13G/A
PCSC · G70077105
0.6% 10/29/2026
Event 9/30/2026
Corbus Pharmaceuticals Holdings, Inc. 13G/A
CRBP · 21833P301
0% 10/29/2026
Event 9/16/2026
Tectonic Therapeutic, Inc. 13G/A
TECX · 878972108
2.5% 10/29/2026
Event 9/30/2026
ProQR Therapeutics NV 13G
PRQR · N71542109
6.3% 7/29/2026
Event 6/30/2026
Eloxx Pharmaceuticals Inc 13G
ELOX · 29014R103
9.9% 7/27/2026
Event 6/30/2026
uniQure N.V. 13G/A
QURE · N90064101
4.5% 7/20/2026
Event 6/30/2026
Sera Prognostics, Inc. 13G/A
SERA · 81749D107
7.2% 7/15/2026
Event 6/30/2026
Quoin Pharmaceuticals, Ltd. 13G/A
QNRX · 74907L409
4.2% 4/29/2026
Event 4/1/2026
InspireMD, Inc. 13G/A
NSPR · 45779A846
7.5% 2/2/2026
Event 12/31/2025
Immunic, Inc. 13G/A
IMUX · 4525EP101
6.9% 2/2/2026
Event 12/31/2025
Precision BioSciences, Inc. 13G
DTIL · 74019P207
8.9% 1/27/2026
Event 12/31/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.